Heesen Christoph, Köpke S, Richter T, Kasper J
Dept. of Neurology, University Medical Center, Martinistr. 52, 20246, Hamburg, Germany.
J Neurol. 2007 May;254 Suppl 2:II116-21. doi: 10.1007/s00415-007-2028-z.
Shared decision making is increasingly recognised as the ideal model of patient-physician communication especially in chronic diseases with partially effective treatments such as multiple sclerosis (MS). Since 2001, we studied prerequisites for patient participation in decision making as well as the effects of evidence-based patient information on decision making processes in MS. In pre-studies we found that 80% of MS patients demand autonomous roles in treatment decisions which contrasts to a poor knowledge of risks. On the other hand MS patients are not disturbed by evidence-based, balanced complex information. MS patients can understand this kind of information and are able to transfer new abilities to other situations. Major information interests were related to symptom alleviation, diagnostic procedures and prognosis. Currently, we study the effects of a 4 hour education programme on relapse management versus an information leaflet as controls in 150 RR MS patients in a randomised-controlled trial. In a second trial including 280 MS patients we study the effects of an evidence-based decision aid on immunotherapy on decisional role preference and performance in the patient physician encounter. Results at the end of 2006 will show to which extent patient education with a focus on evidence-based patient information influences participation in the decision making process. Assuming that patient education programmes will enhance self-management abilities and the sense of control over the disease with enhanced quality of life and well-being, further modules covering all aspects of MS are to be developed.
共同决策越来越被视为医患沟通的理想模式,尤其是在像多发性硬化症(MS)这种治疗效果部分有效的慢性病中。自2001年以来,我们研究了患者参与决策的先决条件以及循证患者信息对MS决策过程的影响。在前期研究中,我们发现80%的MS患者要求在治疗决策中发挥自主作用,这与他们对风险的了解不足形成对比。另一方面,MS患者不会被循证、平衡的复杂信息所困扰。MS患者能够理解这类信息,并能够将新能力应用于其他情况。主要的信息兴趣与症状缓解、诊断程序和预后有关。目前,我们正在一项随机对照试验中,研究一项为期4小时的复发管理教育计划与作为对照的信息传单对150例复发缓解型MS患者的影响。在另一项包括280例MS患者的试验中,我们研究一种基于证据的免疫治疗决策辅助工具对医患交流中决策角色偏好和表现的影响。2006年底的结果将显示,以循证患者信息为重点的患者教育在多大程度上影响决策过程中的参与度。假设患者教育计划将提高自我管理能力和对疾病的控制感,同时提高生活质量和幸福感,还将开发涵盖MS各个方面的更多模块。